Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Pizzolato G, Kaminski H, Tosolini M, Franchini DM, Pont F, Martins F, Valle C, Labourdette D, Cadot S, Quillet-Mary A, Poupot M, Laurent C, Ysebaert L, Meraviglia S, Dieli F, Merville P, Milpied P, Déchanet-Merville J, Fournié JJ.

Proc Natl Acad Sci U S A. 2019 Jun 11;116(24):11906-11915. doi: 10.1073/pnas.1818488116. Epub 2019 May 22.

PMID:
31118283
2.

Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson's Disease Patients.

D'Andrea G, Pizzolato G, Gucciardi A, Stocchero M, Giordano G, Baraldi E, Leon A.

Sci Rep. 2019 Apr 16;9(1):6151. doi: 10.1038/s41598-019-42535-w.

3.

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion.

Lo Presti E, Pizzolato G, Corsale AM, Caccamo N, Sireci G, Dieli F, Meraviglia S.

Front Immunol. 2018 Jun 15;9:1395. doi: 10.3389/fimmu.2018.01395. eCollection 2018. Review.

4.

γδ cells and tumor microenvironment: A helpful or a dangerous liason?

Lo Presti E, Di Mitri R, Pizzolato G, Mocciaro F, Dieli F, Meraviglia S.

J Leukoc Biol. 2018 Mar;103(3):485-492. doi: 10.1002/JLB.5MR0717-275RR. Epub 2017 Dec 14. Review.

PMID:
29345336
5.

Current Advances in γδ T Cell-Based Tumor Immunotherapy.

Lo Presti E, Pizzolato G, Gulotta E, Cocorullo G, Gulotta G, Dieli F, Meraviglia S.

Front Immunol. 2017 Oct 27;8:1401. doi: 10.3389/fimmu.2017.01401. eCollection 2017. Review.

6.

Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study.

Caruso P, Naccarato M, Faoro V, Pracella D, Borando M, Dotti I, Koscica N, Stanta G, Pizzolato G, Manganotti P.

J Stroke Cerebrovasc Dis. 2016 Sep;25(9):2196-202. doi: 10.1016/j.jstrokecerebrovasdis.2016.03.006. Epub 2016 Jul 15.

PMID:
27425766
7.

Blood transcriptomics of drug-naïve sporadic Parkinson's disease patients.

Calligaris R, Banica M, Roncaglia P, Robotti E, Finaurini S, Vlachouli C, Antonutti L, Iorio F, Carissimo A, Cattaruzza T, Ceiner A, Lazarevic D, Cucca A, Pangher N, Marengo E, di Bernardo D, Pizzolato G, Gustincich S.

BMC Genomics. 2015 Oct 28;16:876. doi: 10.1186/s12864-015-2058-3.

8.

Amino acid supplementation in l-dopa treated Parkinson's disease patients.

Cucca A, Mazzucco S, Bursomanno A, Antonutti L, Di Girolamo FG, Pizzolato G, Koscica N, Gigli GL, Catalan M, Biolo G.

Clin Nutr. 2015 Dec;34(6):1189-94. doi: 10.1016/j.clnu.2014.12.007. Epub 2014 Dec 23.

PMID:
25660414
9.

Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study.

Walker Z, Moreno E, Thomas A, Inglis F, Tabet N, Rainer M, Pizzolato G, Padovani A; DaTSCAN DLB Phase 4 Study Group.

Br J Psychiatry. 2015 Feb;206(2):145-52. doi: 10.1192/bjp.bp.114.148643. Epub 2014 Nov 27.

PMID:
25431431
10.

Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.

Vu B, Wovkulich P, Pizzolato G, Lovey A, Ding Q, Jiang N, Liu JJ, Zhao C, Glenn K, Wen Y, Tovar C, Packman K, Vassilev L, Graves B.

ACS Med Chem Lett. 2013 Apr 2;4(5):466-9. doi: 10.1021/ml4000657. eCollection 2013 May 9.

11.

Long-range neural activity evoked by premotor cortex stimulation: a TMS/EEG co-registration study.

Zanon M, Battaglini PP, Jarmolowska J, Pizzolato G, Busan P.

Front Hum Neurosci. 2013 Nov 25;7:803. doi: 10.3389/fnhum.2013.00803. eCollection 2013.

12.

Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.

Mimmi MC, Finato N, Pizzolato G, Beltrami CA, Fogolari F, Corazza A, Esposito G.

Anal Cell Pathol (Amst). 2013;36(3-4):71-83. doi: 10.3233/ACP-130082.

13.

The incidence of amyotrophic lateral sclerosis in Friuli Venezia Giulia, Italy, from 2002 to 2009: a retrospective population-based study.

Drigo D, Verriello L, Clagnan E, Eleopra R, Pizzolato G, Bratina A, D'Amico D, Sartori A, Masè G, Simonetto M, Lazzarino de Lorenzo L, Cecotti L, Zanier L, Pisa F, Barbone F.

Neuroepidemiology. 2013;41(1):54-61. doi: 10.1159/000350015. Epub 2013 May 25.

PMID:
23711404
14.

Smooth muscle cells of human intracranial aneurysms assume phenotypic features similar to those of the atherosclerotic plaque.

Coen M, Burkhardt K, Bijlenga P, Gabbiani G, Schaller K, Kövari E, Rüfenacht DA, Ruíz DS, Pizzolato G, Bochaton-Piallat ML.

Cardiovasc Pathol. 2013 Sep-Oct;22(5):339-44. doi: 10.1016/j.carpath.2013.01.083. Epub 2013 Mar 5.

PMID:
23466011
15.

Discovery of a highly potent, orally active mitosis/angiogenesis inhibitor r1530 for the treatment of solid tumors.

Liu JJ, Higgins B, Ju G, Kolinsky K, Luk KC, Packman K, Pizzolato G, Ren Y, Thakkar K, Tovar C, Zhang Z, Wovkulich PM.

ACS Med Chem Lett. 2013 Jan 15;4(2):259-63. doi: 10.1021/ml300351e. eCollection 2013 Feb 14.

16.

Optic nerve and its arterial-venous vascularization: an ultrasonologic study in multiple sclerosis patients and healthy controls.

Carraro N, Servillo G, Maria Sarra V, Bignamini A, Pizzolato G, Zorzon M.

J Neuroimaging. 2014 May-Jun;24(3):273-7. doi: 10.1111/j.1552-6569.2012.00758.x. Epub 2012 Dec 28.

PMID:
23279290
17.

A case of nocturnal frontal lobe epilepsy in a patient with spinocerebellar ataxia type 17.

Belluzzo M, Musho-Ilbeh S, Monti F, Pizzolato G.

Seizure. 2012 Dec;21(10):805-6. doi: 10.1016/j.seizure.2012.08.006. Epub 2012 Sep 19. No abstract available.

18.

Transcranial magnetic stimulation and preparation of visually-guided reaching movements.

Busan P, Zanon M, Vinciati F, Monti F, Pizzolato G, Battaglini PP.

Front Neuroeng. 2012 Aug 8;5:18. doi: 10.3389/fneng.2012.00018. eCollection 2012.

19.

Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.

Tongiorgi E, Sartori A, Baj G, Bratina A, Di Cola F, Zorzon M, Pizzolato G.

J Neurol Sci. 2012 Sep 15;320(1-2):161-5. doi: 10.1016/j.jns.2012.07.016. Epub 2012 Jul 24.

PMID:
22836016
20.

Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.

Specogna I, Casagrande F, Lorusso A, Catalan M, Gorian A, Zugna L, Longo R, Zorzon M, Naccarato M, Pizzolato G, Ukmar M, Cova MA.

Radiol Med. 2012 Dec;117(8):1398-407. doi: 10.1007/s11547-012-0845-3. Epub 2012 Jun 22.

PMID:
22729506
21.

18F-FDG-PET/CT.

Chierichetti F, Pizzolato G.

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):138-50. Review.

22.

Deep brain stimulation for movement disorders.

Pizzolato G, Mandat T.

Front Integr Neurosci. 2012 Jan 25;6:2. doi: 10.3389/fnint.2012.00002. eCollection 2012.

23.

Motor excitability evaluation in developmental stuttering: a transcranial magnetic stimulation study.

Busan P, D'Ausilio A, Borelli M, Monti F, Pelamatti G, Pizzolato G, Fadiga L.

Cortex. 2013 Mar;49(3):781-92. doi: 10.1016/j.cortex.2011.12.002. Epub 2011 Dec 16.

PMID:
22225881
24.

Treatment of fatigue in multiple sclerosis patients: a neurocognitive approach.

Catalan M, De Michiel A, Bratina A, Mezzarobba S, Pellegrini L, Marcovich R, Tamiozzo F, Servillo G, Zugna L, Bosco A, Sartori A, Pizzolato G, Zorzon M.

Rehabil Res Pract. 2011;2011:670537. doi: 10.1155/2011/670537. Epub 2011 Sep 8.

25.

A case of hypocalcemia-related epilepsia partialis continua.

Belluzzo M, Monti F, Pizzolato G.

Seizure. 2011 Nov;20(9):720-2. doi: 10.1016/j.seizure.2011.04.013. Epub 2011 May 28.

26.

Pyrazolobenzodiazepines: part I. Synthesis and SAR of a potent class of kinase inhibitors.

Liu JJ, Daniewski I, Ding Q, Higgins B, Ju G, Kolinsky K, Konzelmann F, Lukacs C, Pizzolato G, Rossman P, Swain A, Thakkar K, Wei CC, Miklowski D, Yang H, Yin X, Wovkulich PM.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):5984-7. doi: 10.1016/j.bmcl.2010.08.079. Epub 2010 Aug 21.

PMID:
20832307
27.

Very early versus delayed mobilisation after stroke.

Stokelj D, Ilbeh SM, Granato A, Servillo G, Pizzolato G, Grandi FC.

Neuroepidemiology. 2010;35(3):163-4. doi: 10.1159/000315154. Epub 2010 Jun 23. No abstract available.

28.

Acupuncture in tension-type headache.

Granato A, Chiodo Grandi F, Stokelj D, Musho S, Pizzolato G.

Neuroepidemiology. 2010 Aug;35(2):160-2. doi: 10.1159/000315042. Epub 2010 Jun 23. No abstract available.

29.

Possible Anandamide and Palmitoylethanolamide involvement in human stroke.

Naccarato M, Pizzuti D, Petrosino S, Simonetto M, Ferigo L, Grandi FC, Pizzolato G, Di Marzo V.

Lipids Health Dis. 2010 May 14;9:47. doi: 10.1186/1476-511X-9-47.

30.

Trace amine metabolism in Parkinson's disease: low circulating levels of octopamine in early disease stages.

D'Andrea G, Nordera G, Pizzolato G, Bolner A, Colavito D, Flaibani R, Leon A.

Neurosci Lett. 2010 Jan 29;469(3):348-51. doi: 10.1016/j.neulet.2009.12.025. Epub 2009 Dec 21.

PMID:
20026245
31.

Cortical connections between dorsal and ventral visual streams in humans: Evidence by TMS/EEG co-registration.

Zanon M, Busan P, Monti F, Pizzolato G, Battaglini PP.

Brain Topogr. 2010 Jan;22(4):307-17. doi: 10.1007/s10548-009-0103-8. Epub 2009 Jun 5.

PMID:
19499197
32.

Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients.

Senzolo M, Pizzolato G, Ferronato C, Chierichetti F, Boccagni P, Dam M, Burra P.

Transplant Proc. 2009 May;41(4):1295-6. doi: 10.1016/j.transproceed.2009.03.087.

PMID:
19460543
33.

Involvement of ipsilateral parieto-occipital cortex in the planning of reaching movements: evidence by TMS.

Busan P, Jarmolowska J, Semenic M, Monti F, Pelamatti G, Pizzolato G, Battaglini PP.

Neurosci Lett. 2009 Aug 28;460(2):112-6. doi: 10.1016/j.neulet.2009.05.028. Epub 2009 May 18.

PMID:
19450660
34.

Parieto-occipital cortex and planning of reaching movements: a transcranial magnetic stimulation study.

Busan P, Monti F, Semenic M, Pizzolato G, Battaglini PP.

Behav Brain Res. 2009 Jul 19;201(1):112-9. doi: 10.1016/j.bbr.2009.01.040. Epub 2009 Feb 11.

PMID:
19428624
35.

Effect of transcranial magnetic stimulation (TMS) on parietal and premotor cortex during planning of reaching movements.

Busan P, Barbera C, Semenic M, Monti F, Pizzolato G, Pelamatti G, Battaglini PP.

PLoS One. 2009;4(2):e4621. doi: 10.1371/journal.pone.0004621. Epub 2009 Feb 27.

36.

Acute hemorrhagic leukoencephalitis with atypical features.

Catalan M, Naccarato M, Grandi FC, Capozzoli F, Koscica N, Pizzolato G.

Neurol Sci. 2009 Feb;30(1):55-7. doi: 10.1007/s10072-008-0003-9. Epub 2009 Jan 15.

PMID:
19145402
37.

Dysembryoplastic neuroepithelial tumour as a cause of coma.

Pollo C, Pizzolato GP, Fransen P, Cox JN, Rilliet B.

J Clin Neurosci. 1998 Oct;5(4):453-7.

PMID:
18639078
38.

Acute Akinesia, an unusual complication in Parkinson's Disease: a case report.

Simonetto M, Ferigo L, Zanet L, Capus L, Antonutti L, Zorzon M, Pizzolato G.

Neurol Sci. 2008 Jun;29(3):181-3. doi: 10.1007/s10072-008-0933-2. Epub 2008 Jul 9.

PMID:
18612768
39.

Risk factors for vascular dementia: hypotension as a key point.

Moretti R, Torre P, Antonello RM, Manganaro D, Vilotti C, Pizzolato G.

Vasc Health Risk Manag. 2008;4(2):395-402. Review.

40.

Different responses to rivastigmine in subcortical vascular dementia and multi-infarct dementia.

Moretti R, Torre P, Antonello RM, Cazzato G, Pizzolato G.

Am J Alzheimers Dis Other Demen. 2008 Apr-May;23(2):167-76. doi: 10.1177/1533317507312558. Epub 2008 Jan 9.

PMID:
18184948
41.

Rivastigmine and Parkinson dementia complex.

Moretti R, Torre P, Vilotti C, Antonello RM, Pizzolato G.

Expert Opin Pharmacother. 2007 Apr;8(6):817-29.

PMID:
17425477
42.

Memantine in the treatment of dementia.

Maggiore C, Locatelli L, Grandi FC, Pizzolato G; Cochrane Neurological Network.

Neuroepidemiology. 2007;28(2):118-9. Epub 2007 Apr 4. No abstract available.

PMID:
17409774
43.

Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease.

Senzolo M, Pizzolato G, Dam M, Sturniolo GC, Burra P.

Psychiatry Clin Neurosci. 2007 Apr;61(2):209-10. No abstract available.

44.

Peripheral neuropathy in hepatitis C virus-related mixed cryoglobulinaemia: existing treatments and a positive symptomatic response to oxcarbazepine.

Moretti R, Torre P, Antonello RM, Cattaruzza T, Pizzolato G.

Funct Neurol. 2006 Jul-Sep;21(3):137-40.

PMID:
17049131
45.

Fulminant Lewy body disease.

Momjian-Mayor I, Pizzolato GP, Burkhardt K, Landis T, Coeytaux A, Burkhard PR.

Mov Disord. 2006 Oct;21(10):1748-51.

PMID:
16830307
46.

Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer's disease: risks or benefits.

Moretti R, Torre P, Antonello RM, Pizzolato G.

Expert Rev Neurother. 2006 May;6(5):705-10. Review.

PMID:
16734518
47.

Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomas.

Jenny B, Harrison JA, Baetens D, Tille JC, Burkhardt K, Mottaz H, Kiss JZ, Dietrich PY, De Tribolet N, Pizzolato GP, Pepper MS.

J Pathol. 2006 May;209(1):34-43.

PMID:
16523449
48.

[Role of the cerebellum in the control of distal motor activities in patients with akinetic-rigid Parkinson disease].

Moretti R, Torre P, Antonello RM, Ukmar M, Cazzato G, Pizzolato G.

Recenti Prog Med. 2005 Dec;96(12):599-603. Italian.

PMID:
16496744
49.

Nontraumatic headache in the Emergency Department: a survey in the province of Trieste.

Relja G, Granato A, Capozzoli F, Maggiore C, Catalan M, Pizzolato G, Zalukar W, Livia V, Gregorutti S, Zorzon M.

J Headache Pain. 2005 Sep;6(4):298-300.

50.

Evaluation of pig esophageal mucosa as a permeability barrier model for buccal tissue.

Diaz Del Consuelo I, Pizzolato GP, Falson F, Guy RH, Jacques Y.

J Pharm Sci. 2005 Dec;94(12):2777-88.

PMID:
16258996

Supplemental Content

Loading ...
Support Center